The Lewis Upshur Animal Control Facility has joined the IDEXX shelter program, and it has allowed them to get new ...

The pet care industry is growing, providing IDEXX with significant growth opportunities. Check out why I rate IDXX stock as a ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

The Lewis-Upshur Animal Control Facility has obtained a new machine to test animals for tick-borne diseases and perform ...

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets.

The Companion Animal Group diagnostics segment registered a 6% growth, driving the overall positive earnings performance. Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by ...

Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994. Idexx Labs reported quarterly ...

With a market cap of $33 billion, IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water ...

Idexx Laboratories, a global leader in veterinary ... Its operations are primarily anchored by the Companion Animal Group (CAG), which caters to the increasing demand for advanced pet care ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the ...